Nike On Pace for Largest Percent Increase Since September 2023 — Data Talk
NIKE, Inc. Class B (NKE) is currently at $78.25, up $3.61 or 4.84%
--Would be highest close since June 27, 2024, when it closed at $94.19
--On pace for largest percent increase since Sept. 29, 2023, when it rose 6.68%
--Currently up seven of the past eight days
--Currently up six consecutive days; up 9.56% over this period
--Longest winning streak since Oct. 18, 2023, when it rose for seven straight trading days
--Best six day stretch since the six days ending Dec. 29, 2022, when it rose 13.7%
--Up 4.53% month-to-date
--Down 27.93% year-to-date
--Down 55.92% from its all-time closing high of $177.51 on Nov. 5, 2021
--Down 26.56% from 52 weeks ago (Aug. 15, 2023), when it closed at $106.55
--Down 36.2% from its 52-week closing high of $122.64 on Dec. 19, 2023
--Up 10.07% from its 52-week closing low of $71.09 on July 24, 2024
--Traded as high as $78.25; highest intraday level since June 28, 2024, when it hit $79.05
--Up 4.84% at today's intraday high; largest intraday percent increase since Sept. 29, 2023, when it rose as much as 10.98%
--Best performer in the DJIA today
--Third best performer in the S&P 500 today
--Contributed 23.72 points to the DJIA so far today
All data as of 10:44:27 AM ET
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
August 13, 2024 11:01 ET (15:01 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
What’s the Difference Between the CPI and PCE Indexes?
-
Micron Earnings: Great Guidance but Stock Now Looks Fairly Valued
-
August PCE Report Forecasts Show More Good News on Inflation
-
AI Stocks May Be Down, but Don’t Count Them Out
-
4 Stocks to Buy as the Fed Cuts Interest Rates
-
Markets Brief: The Uncertain Path to Neutral Interest Rates
-
What’s Happening in the Markets This Week
-
Where Top Stock Fund Managers Are Looking Next After the Fed Rate Cut
-
Our Top Pick for Investing in US Renewable Energy
-
Undervalued by 25% and Yielding 5%, This Stock Is a Buy
-
Can AI Predict Future Stock Returns?
-
The Best Energy Stocks to Buy Now
-
10 Undervalued Wide-Moat Stocks
-
Obesity Drugs: Can New Firms Take Market Share From Eli Lilly and Novo Nordisk?
-
New 4-Star Stocks
-
Intel Fair Value Left Unchanged Despite Qualcomm Takeover Talk